Headquartered in Irvine, California, Sientra is a medical aesthetics company offering leading transformative treatments and technologies focused on progressing the art of plastic surgery and making a difference in patients’ lives. With unrivaled safety, state-of-the-art science  and exceptional service; paired with unparalleled partnerships with plastic surgeons, the Sientra portfolio of proprietary innovations radically advances how plastic surgeons think, work and care for their patients. The company’s core breast products segment includes its state-of-the-art Sientra breast implants and its ground-breaking dual-port breast tissue expander, AlloX2®. In addition, the Sientra portfolio also includes their novel fat transfer device, Viality™, the first and only Lipoaspirate Wash System using AuraClens™ and BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons (data on file).


Nasdaq: SIEN

Stock Quote: NASD

$1.63 -0.01
Volume 75,916
Previous Close 1.64
Intraday High 1.70
Intraday Low 1.59
Pricing delayed 20 minutes
Price Change % Change -0.61% 52 Week High 16.50 52 Week Low 1.25 Today's Open 1.63 Jun 02, 2023 04:00 PM

Investor Contact

Sientra Investor Relations